Cephalosporin
Cephalosporin
Cephalosporin
Contents
[hide]
• 1 History
• 2 Mode of action
• 3 Clinical use
o 3.1 Indications
o 3.2 Adverse effects
• 4 Classification
o 4.1 First generation
o 4.2 Second generation
o 4.3 Third generation
o 4.4 Fourth generation
o 4.5 Fifth generation
o 4.6 Yet to be classified
• 5 See also
• 6 References
• 7 Further reading
• 8 External links
[edit] History
Cephalosporin compounds were first isolated from cultures of Cephalosporium
acremonium from a sewer in Sardinia in 1948 by Italian scientist Giuseppe Brotzu [2]. He
noticed that these cultures produced substances that were effective against Salmonella
typhi, the cause of typhoid fever, which had beta-lactamase. Guy Newton and Edward
Abraham at the Sir William Dunn School of Pathology at the University of Oxford
isolated cephalosporin C. The cephalosporin nucleus, 7-aminocephalosporanic acid (7-
ACA), was derived from cephalosporin C and proved to be analogous to the penicillin
nucleus 6-aminopenicillanic acid, but it was not sufficiently potent for clinical use.
Modification of the 7-ACA side-chains resulted in the development of useful antibiotic
agents, and the first agent cephalothin (cefalotin) was launched by Eli Lilly in 1964.
Cephalosporins are indicated for the prophylaxis and treatment of infections caused by
bacteria susceptible to this particular form of antibiotic. First-generation cephalosporins
are predominantly active against Gram-positive bacteria, and successive generations have
increased activity against Gram-negative bacteria (albeit often with reduced activity
against Gram-positive organisms).
Common adverse drug reactions (ADRs) (≥1% of patients) associated with the
cephalosporin therapy include: diarrhea, nausea, rash, electrolyte disturbances, and/or
pain and inflammation at injection site. Infrequent ADRs (0.1–1% of patients) include:
vomiting, headache, dizziness, oral and vaginal candidiasis, pseudomembranous colitis,
superinfection, eosinophilia, and/or fever.
[edit] Classification
The cephalosporin nucleus can be modified to gain different properties. Cephalosporins
are sometimes grouped into "generations" by their antimicrobial properties. The first
cephalosporins were designated first generation, whereas later, more extended spectrum
cephalosporins were classified as second-generation cephalosporins. Each newer
generation of cephalosporins has significantly greater Gram-negative antimicrobial
properties than the preceding generation, in most cases with decreased activity against
Gram-positive organisms. Fourth-generation cephalosporins, however, have true broad
spectrum activity.
Some state that although cephalosporins can be divided into five or even six generations,
the usefulness of this organization system is of limited clinical relevance.[11]
[edit] First generation
Structure of the classical cephalosporins
• Cefacetrile (cephacetrile)
• Cefadroxil (cefadroxyl; Duricef)
• Cephalexin (cephalexin; Keflex)
• Cefaloglycin (cephaloglycin)
• Cefalonium (cephalonium)
• Cefaloridine (cephaloradine)
• Cefalotin (cephalothin; Keflin)
• Cefapirin (cephapirin; Cefadryl)
• Cefatrizine
• Cefazaflur
• Cefazedone
• Cefazolin (cephazolin; Ancef, Kefzol)
• Cefradine (cephradine; Velosef)
• Cefroxadine
• Ceftezole
• Cefmetazole
• Cefotetan
• Cefoxitin
• Cefcapene
• Cefdaloxime
• Cefdinir (Omnicef, Kefnir)
• Cefditoren
• Cefetamet
• Cefixime (Suprax)
• Cefmenoxime
• Cefodizime
• Cefotaxime (Claforan)
• Cefovecin (Convenia)
• Cefpimizole
• Cefpodoxime (Vantin, PECEF)
• Cefteram
• Ceftibuten (Cedax)
• Ceftiofur
• Ceftiolene
• Ceftizoxime (Cefizox)
• Ceftriaxone (Rocephin)
• Cefoperazone (Cefobid)
• Ceftazidime (Fortum, Fortaz)
• Cefclidine
• Cefepime (Maxipime)
• Cefluprenam
• Cefoselis
• Cefozopran
• Cefpirome(Cefrom)
• Cefquinome
• Oxacephems: flomoxef
Ceftobiprole has been described as "fifth generation",[14][15] though acceptance for this
terminology is not universal.
Ceftobiprole (and the soluble prodrug medocaril) are on the FDA fast-track. Ceftobiprole
has powerful antipseudomonal characteristics and appears to be less susceptible to
development of resistance.
These cephems have progressed far enough to be named, but have not been assigned to a
particular generation.
• Cefaloram
• Cefaparole
• Cefcanel
• Cefedrolor
• Cefempidone
• Cefetrizole
• Cefivitril
• Cefmatilen
• Cefmepidium
• Cefoxazole
• Cefrotil
• Cefsumide
• Ceftaroline
• Ceftioxide
• Cefuracetime